| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Viracta Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 500K | 14 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VIRX | Viracta Therapeutics, Inc. | 14 May 2024 | 1 | $0 | 4 | Chief Financial Officer | 16 May 2024, 16:26 |
| VIRX | Viracta Therapeutics, Inc. | 13 May 2024 | 0 | $0 | 3 | Chief Financial Officer | 16 May 2024, 16:23 |